share_log

DEF 14A: Definitive information statements

DEF 14A: Definitive information statements

DEF 14A：股東委託書決議
美股SEC公告 ·  10/28 17:19

Moomoo AI 已提取核心訊息

Conduit Pharmaceuticals Inc. has announced the scheduling of its virtual annual meeting of stockholders to be held on December 18, 2024. The meeting will address several key proposals, including the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the adoption of an amendment for a reverse stock split of the company's common stock. The reverse stock split proposal aims to consolidate issued shares into a lesser number by a ratio of not less than 1-for-10 and not more than 1-for-100, with the exact ratio to be determined by the Board. This move is intended to increase the per-share price of the company's stock, potentially...Show More
Conduit Pharmaceuticals Inc. has announced the scheduling of its virtual annual meeting of stockholders to be held on December 18, 2024. The meeting will address several key proposals, including the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the adoption of an amendment for a reverse stock split of the company's common stock. The reverse stock split proposal aims to consolidate issued shares into a lesser number by a ratio of not less than 1-for-10 and not more than 1-for-100, with the exact ratio to be determined by the Board. This move is intended to increase the per-share price of the company's stock, potentially avoiding delisting from the Nasdaq and attracting more investors and analysts. The meeting will also allow for the transaction of other matters that may properly come before the meeting. Only stockholders of record as of October 25, 2024, are entitled to notice of and to vote at the meeting. The company has emphasized the importance of stockholder votes and has provided instructions for voting by internet or by mail.
Conduit Pharmaceuticals公司宣佈將於2024年12月18日舉行虛擬股東年會。會議將討論幾項關鍵提案，包括選舉六位董事、批准Marcum LLP擔任截至2024年12月31日財政年度的獨立註冊會計師，以及通過關於公司普通股的有償股票拆細提案修正案。有償股票拆細提案旨在以不低於1比10、不高於1比100的比率將已發行股份合併至較少數量，具體比率將由董事會確定。此舉旨在提高公司股票的每股價格，有可能避免在納斯達克上市公司的除牌，並吸引更多投資者和分析師。會議還將允許就可能在會議上妥善提出的其他事項進行交易。僅2014年10月25日作爲記錄股東的股東有權獲得會議通知並投票。公司強調了股東投票的重要性，並提供了通過互聯網或郵寄投票的說明。
Conduit Pharmaceuticals公司宣佈將於2024年12月18日舉行虛擬股東年會。會議將討論幾項關鍵提案，包括選舉六位董事、批准Marcum LLP擔任截至2024年12月31日財政年度的獨立註冊會計師，以及通過關於公司普通股的有償股票拆細提案修正案。有償股票拆細提案旨在以不低於1比10、不高於1比100的比率將已發行股份合併至較少數量，具體比率將由董事會確定。此舉旨在提高公司股票的每股價格，有可能避免在納斯達克上市公司的除牌，並吸引更多投資者和分析師。會議還將允許就可能在會議上妥善提出的其他事項進行交易。僅2014年10月25日作爲記錄股東的股東有權獲得會議通知並投票。公司強調了股東投票的重要性，並提供了通過互聯網或郵寄投票的說明。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間